Publication of a new systematic review provides insights into clinical outcome measures for DM2.
Induced pluripotential stem cells (iPSCs) from DM2 provide new tools for CNS-focused mechanistic and translational studies.
A new publication finds a complex mechanism of action of furamidine in DM1 models.
Close monitoring of respiratory function reduces respiratory complications in DM1.
MDF has released a Request for Applications for projects that address the evaluation of genome editing strategies for DM1. The focus of this RFA is early stage discovery and development of in vivo genome editing technologies. Up to two awards of $250,000 each are planned.